Showing results (81-90 of 101) with videos related to
Sort By:
Pageof 11
Oncoimmunology|November 15, 2021
Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resectionDaniel Delitto, Daniel J Zabransky, Fangluo Chen, et al.Nature Cancer|November 19, 2021
Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor ImmunityWon Jin Ho, Qingfeng Zhu, Jennifer Durham, et al.Journal for Immunotherapy of Cancer|April 21, 2026
Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinomaHoward L Li, Soren Charmsaz, Benjamin J Reisman, et al.Cell Systems|August 8, 2024
PanIN and CAF transitions in pancreatic carcinogenesis revealed with spatial data integrationAlexander T F Bell, Jacob T Mitchell, Ashley L Kiemen, et al.Cancer Immunology Research|August 15, 2025
Neoadjuvant immunotherapy promotes the formation of mature tertiary lymphoid structures in a remodeled pancreatic tumor microenvironmentDimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel, et al.Nature Medicine|November 25, 2025
A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trialMarina Baretti, Allison M Kirk, Brian H Ladle, et al.Cancer Discovery|July 16, 2026
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohortsS Daniel Haldar, Amanda L Huff, Hejia Henry Wang, et al.Nature Communications|April 21, 2025
Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitorsChester Kao, Soren Charmsaz, Hua-Ling Tsai, et al.Biorxiv : the Preprint Server for Biology|October 10, 2024
Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic respondersDimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel, et al.Cell Systems|April 20, 2023
Uncovering the spatial landscape of molecular interactions within the tumor microenvironment through latent spacesAtul Deshpande, Melanie Loth, Dimitrios N Sidiropoulos, et al.Pageof 11